ASELAGE STEVE 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 2, 2021
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Award
Common Stock
2021-11-30$12.06/sh+414$4,993→ 32,858 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000.